x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

The IMID Forum

The Immune-Mediated Inflammatory Disease Forum

Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.

education

All Episodes

00:59:44

Forum LIVE: Managing Patients During COVID

The IMID Forum ·

2021/03/05

Professor Leonard Calabrese offers the latest advice on managing rheumatic patients during the pandemic and Professor Kimme Hyrich discusses the learnings from the COVID-19 Global Rheumatology Alliance registries, a year on from their inception.

en

00:31:14

Rheumatology Author Professor Lee Simon: Pain in RA

The IMID Forum ·

2021/03/03

Dr Lee Simon, Principal Scientist in SDG LLG, Cambridge, US. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Dr Lee Simon discusses pain in RA

en

00:20:30

Rheumatology Author Professor Tsutomu Takeuchi:...

The IMID Forum ·

2021/03/03

Professor Tsutomu Takeuchi, HVice-President at Keio University and Professor of Medicine in the Division of Rheumatology and Clinical Immunology at Keio University School of Medicine. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Tsutomu Takeuchi discusses how upadacitinib monotherapy vs methotrexate monotherapy in methotrexate-naïve Japanese patients with RA

en

00:33:41

Rheumatology Author Prof René Westhovens: Filgotinib

The IMID Forum ·

2021/02/19

Professor René Westhovens, Emeritus Prof of Rheumatology at the KU Leuven Belgium and a >30 year track in clinical research in Rheumatoid Arthritis. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Professor René Westhovens discusses his latest paper on use of filgotinib in combination with methotrexate or as filgotinib monotherapy versus methotrexate monotherapy in patients with active RA.

en

00:11:47

Discussing Rheumatology: February 2021 Podcast

The IMID Forum ·

2021/02/19

Prof Iain McInnes discusses papers on filgotinib and the involvement of pain in RA. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.

en

00:25:51

Perspectives in Inflammation - Dr Grace Wright

The IMID Forum ·

2021/01/29

Founder and President of the Association of Women in Rheumatology. In this podcast Dr Grace C Wright discusses her careeer and the future of AWIR. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world-leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

en

00:25:13

Rheumatology Author Prof György Nagy: EULAR

The IMID Forum ·

2021/01/27

Professor György Nagy from the Semmelweis University, Hungry. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Professor György Nagy discusses his latest paper on EULAR definition of difficult-to-treat RA

en

00:24:07

Rheumatology Author Prof Philip Mease: Upadacitinib...

The IMID Forum ·

2021/01/18

Professor Philip Mease from the University of Washington School of Medicine. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Professor Philip Mease discusses his latest paper on Upadacitinib for Psoriatic Arthritis refractory to biologics.

en

00:10:08

Discussing Rheumatology: JAKi and TNFi

The IMID Forum ·

2021/01/18

Prof Iain McInnes discusses JAK inhibitors and TNFi in RA treatment. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.

en

00:28:20

Perspectives In Inflammation - Professor Weinblatt

The IMID Forum ·

2021/01/11

In this podcast the Past President of ACR, Professor Michael Weinblatt discusses his involvement in the development of methotrexate and the expansion of his unit at the Brigham, alongside Professor Paul Emery. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

en

00:40:41

Rheumatology Author Prof Josef Smolen: Barcitinib

The IMID Forum ·

2021/01/06

Prof Josef Smolen from Medical University of Vienna. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Prof Josef Smolen discusses efficacy of baricitinib in patients with RA

en

00:22:06

Rheumatology Author Dr Kerschbaumer: JAKinibs

The IMID Forum ·

2020/12/29

Dr Andreas Kerschbaumer from Vienna University. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Dr Andreas Kerschbaumer discusses his systematic review paper on “Points to Consider for the Treatment of Immune Mediated Inflammatory Diseases with Janus Kinase Inhibitors

en

00:20:16

Rheumatology Author Roy Fleischmann: Switching...

The IMID Forum ·

2020/12/29

Professor Roy Fleischmann, from the University of Texas Southwestern Medical Centre in Dallas, discusses data from the SELECT-COMPARE trial, where patients with RA were switched between upadacitinib and adalimumab in cases of insufficient response.

en

00:21:18

Rheumatology Author Prof Kevin Winthrop: Tofacitinib

The IMID Forum ·

2020/12/22

Prof Kevin Winthrop from OHSU. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Prof Kevin Winthrop discusses aged based incidence of infections with tofacitinib

en

00:20:16

Discussing Rheumatology: JAK Inhibitors

The IMID Forum ·

2020/12/22

Prof Iain McInnes discusses JAK inhibitors. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.

en

00:22:26

Perspectives in Inflammation - Professor Emery

The IMID Forum ·

2020/12/09

Past President of EULAR and Carol Nachman Prize winner. In this podcast, Professor Paul Emery discusses his work in managing early RA and the growth of his unit at Leeds into a world leading centre for rheumatology research alongside Professor Michael Weinblatt. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

en

00:10:57

Insights at ACR 2020: Highlights from ACR 2020

The IMID Forum ·

2020/11/30

Gain insight into the latest research presented at ACR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition includes a preview of an upcoming Highlights from ACR 2020 course from Professors Kevin Winthrop and Leonard Calabrese, available soon on the CSF website.

en

00:21:58

Rheumatology Author Prof Stanley Cohen: Upadacitinib

The IMID Forum ·

2020/11/25

Prof Stanley Cohen - University of Texas. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Prof Stanley Cohen discusses safety profile of upadacitinib

en

00:07:09

Discussing Rheumatology: Upadacitinib Safety

The IMID Forum ·

2020/11/25

Prof Iain McInnes discusses upadacitinib safety. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com

en

00:31:43

Insights at ACR 2020: Efficacy And Safety Of JAK...

The IMID Forum ·

2020/11/23

Gain insight into the latest research presented at ACR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition includes some great efficacy and safety data on JAK inhibitors from Professors Kevin Winthrop, Stanely Cohen, Ernest Choy and Rene Westhovens.

en

389 results

Similar Podcasts

Science Talk

Albert Einstein College of Medicine

五分钟心理学

柠檬心理

Daily Facts

Amalia Dupray and Montgomery Jones.

Les dents et dodo

BFMTV

Veterinary Clinical Podcasts

The Royal Veterinary College